Skip to content

Clinical trials

Phase 2 Skin Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Phase: Phase 2 Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20035
20043
20054
20076
20086
20094
20102
20119
20132
20147
20152
20161
20172
20182
20194
20205
20213
20222
20233
20242
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Terminated20
Active, not recruiting11
Recruiting7
Withdrawn4
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
H. Lee Moffitt Cancer Center and Research Institute8
Massachusetts General Hospital5
Memorial Sloan Kettering Cancer Center5
M.D. Anderson Cancer Center4
Pfizer3
Genmab2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2
Novartis Pharmaceuticals2
Point Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms96
Melanoma47
Basal Cell Carcinoma11
Neoplasms11
Carcinoma, Squamous Cell10
Cutaneous Squamous Cell Carcinoma10
Carcinoma, Merkel Cell5
Head and Neck Neoplasms5
Neoplasm Metastasis5
HIV Infections4

Trials

Showing 76 to 96 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.